Central and hemicentral retinal vein occlusion: role of anti-platelet aggregation agents and anticoagulants. [electronic resource]
- Ophthalmology Aug 2011
- 1603-11 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1549-4713
10.1016/j.ophtha.2011.04.036 doi
Adolescent Adult Aged Aged, 80 and over Anticoagulants--therapeutic use Aspirin--therapeutic use Cohort Studies Dipyridamole--therapeutic use Female Humans Macular Edema--physiopathology Male Middle Aged Platelet Aggregation Inhibitors--therapeutic use Prospective Studies Retinal Hemorrhage--physiopathology Retinal Vein Occlusion--drug therapy Treatment Outcome Visual Acuity--physiology Visual Field Tests Visual Fields--physiology Warfarin--therapeutic use Young Adult